Cite
HARVARD Citation
Lee, V. et al. (2017). Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma. Medicine. 96 (15), p. . [Online].